Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 9
July 2020
Volume 61, Issue 9
Free
ARVO Imaging in the Eye Conference Abstract  |   July 2020
Agreement between structural and functional tests for detecting central glaucomatous defects
Author Affiliations & Notes
  • Tutul Chakravarti
    Ophthalmology, Glaucoma, Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, San Diego, California, United States
  • Mohamad Moghadam
    Ophthalmology, Glaucoma, Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, San Diego, California, United States
  • Won Hyuk OH
    Ophthalmology, Glaucoma, Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, San Diego, California, United States
  • Christopher Bowd
    Ophthalmology, Glaucoma, Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, San Diego, California, United States
  • James Proudfoot
    Ophthalmology, Glaucoma, Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, San Diego, California, United States
  • Robert N Weinreb
    Ophthalmology, Glaucoma, Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, San Diego, California, United States
  • Linda Zangwill
    Ophthalmology, Glaucoma, Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, San Diego, California, United States
  • Footnotes
    Commercial Relationships   Tutul Chakravarti, None; Mohamad Moghadam, None; Won Hyuk OH, None; Christopher Bowd, None; James Proudfoot, None; Robert Weinreb, Aerie Pharmaceuticals, Allergan, Bausch&Lomb,Eyenovia (C), Heidelberg Engineering, Carl Zeiss Meditec, Konan Medical, Optovue, Centervue, Bausch&Lomb; (F), Toromedes, Meditec-Zeiss (P); Linda Zangwill, Heidelberg Engineering (R), Meditec-Zeiss (P), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc. (F)
  • Footnotes
    Support  NONE
Investigative Ophthalmology & Visual Science July 2020, Vol.61, PB0098. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tutul Chakravarti, Mohamad Moghadam, Won Hyuk OH, Christopher Bowd, James Proudfoot, Robert N Weinreb, Linda Zangwill; Agreement between structural and functional tests for detecting central glaucomatous defects. Invest. Ophthalmol. Vis. Sci. 2020;61(9):PB0098.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess the agreement between qualitative assessment of the macula and circumpapillary RNFL (cpRNFL) using the Spectralis optical coherence tomography (OCT) Hood Glaucoma Report (HGR) and the HFA 24-2C and 10-2 test patterns for detecting central glaucomatous defects.

Methods : 127 eyes of 83 healthy, glaucoma suspect or glaucoma patients who completed OCT, 24-2C and 10-2 VF testing within six months were included.OCT cpRNFL and macula scans were qualitatively assessed based on HGR reports. Inferior and superior cpRNFL defects were defined as the presence of regions outside of normal limitsobserved on the available NSTIN plot.Inferior and superior macula defects were defined subjectively based on the color-coded ganglion cell thickness maps. Central visual field defects (CVFD)were qualitatively assessed from the 10-2 test pattern and 22 central points of the 24-2C test pattern. Superior and inferior CVFDs were defined as the presence of arcuate, partial arcuate or altitudinal defects observed on pattern deviation plots. Cohen’s K was used to assess agreement.

Results : Participant mean age was 67.6years and mean (95% CI) 24-2 MD by eye was -4.06 dB (-5.12 dB, -3.00 dB).Of 127 eyes tested, 70 (55.1%) had structural defects based on OCT reports (43 of 70 based on macula assessment and 69 of 70 based on cpRNFL assessment). 36 (28.3%) eyes had 24-2C CVFD and 52 (40.9%) had 10-2 CVFD based on PD criterion. Of these eyes, 19 had inferior structural defects (18 had macular and 19 had cpRNFL defects) with corresponding superior functional defects. A total of 36 eyes had inferior structural defects without corresponding superior 24-2C CVFDs , while 1 eye had superior CVFD without corresponding structural defects resulting in fair agreement (K=0.358; 95% CI=0.210, 0.536). 21 eyes had superior structural defects (16 had macular and 21 had cpRNFL defects )with corresponding 24-2C inferior CVFD. A total of 31 eyes had superior structural defects without corresponding functional defects while 1 eye had inferior CVFDs without corresponding superior defects resulting in moderate agreement(K=0.428; 0.287, 0.572). Similar results were observed for 10-2 testing.

Conclusions : Agreement for detecting structural and functional central defects was fair to moderate in our sample. The more structural than functional defects and more RNFL than macular defects observed needs to be confirmed in longitudinal studies.

This is a 2020 Imaging in the Eye Conference abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×